Company · DSE:JMISMDL · Pharmaceuticals & healthcare (medical devices) · Analysis · 31 Oct 2026
JMI Syringes: gross margin fell to 8.7% in 9M FY2026 and a flood write-off took FY2026 to a BDT 2.00 loss per share; the 10% cash dividend was kept
Revenue fell 14.7% in the nine months to March 2026, gross margin dropped from 15.0% to 8.7%, and BDT 75.4m of flood-damaged inventory not covered by insurance was written off. Nipro Corporation of Japan owns 50.23%; the balance sheet carries almost no debt.
JMI Syringes & Medical Devices Ltd. (JMISMDL) makes disposable medical devices at a factory in Noapara, Chauddagram, Cumilla: disposable and auto-disable (AD) syringes, infusion sets, scalp vein sets, IV cannulas, urine drainage bags, catheters, blood lancets and a long list of smaller items. Syringes are…